Search companies or stocks...
TRAWTraws Pharma, Inc.
At close · 02 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Traws Pharma, Inc., a clinical stage biopharmaceutical company, focuses on developing small molecule oral product candidates for respiratory viral diseases and cancer. The…
Current stock price of Traws Pharma, Inc. (TRAW) stock is $0.570. The stock price is -3.39% lower in the session. The intraday range can be seen from this page. Volume of Traws Pharma, Inc. (TRAW) stock is 27.80K.
Last updated at 02 Sept 2026, 08:00 pm.
The stock price of Traws Pharma, Inc. (TRAW) can change with earnings, company news, and overall market sentiment. Traws Pharma, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Traws Pharma, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for TRAW on this page is -0.46. EPS on this page is -1.24. Compare those figures with peers and growth expectations before deciding if the current Traws Pharma, Inc. price is justified.
Historical performance for Traws Pharma, Inc. (TRAW) is shown on the price chart on this page. Review multi-period moves alongside volume to see how TRAW reacted to past earnings and market events.
Buying Traws Pharma, Inc. (TRAW) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
